. Fractionation and isolation of the bioactive component enhancing osteoblast differentiation from 30% ethanol extract of Lycii radicis cortex.
. Fractionation and isolation of the bioactive component enhancing osteoblast differentiation from 30% ethanol extract of Lycii radicis cortex. Figure S2 . ALP activity test of the fractions isolated in Figure S1 using the pre-osteoblast MC3T3-E1 cells. Cells were treated with ascorbic acid (50 μg/ml) and β-glycerophosphate (10 mM) and cultured with three different concentrations (1, 5, and 10 mg), and an ALP activity was assessed. Control: non-treated cells. *: p < 0.05 vs. control. Figure S3 . Results of proton nuclear magnetic resonance ( 1 H-NMR). (A) Carbon-13 nuclear magnetic resonance ( 13 C-NMR), (B) mass spectrum, and (C) analyses of the B4 fraction of Supplementary Fig. S1 . Figure S4 . Effects of kukoamine B (KB) on alkaline phosphatase (ALP) activity in preosteoblast MC3T3-E1 cells. Cells were treated with ascorbic acid (50 μg/ml) and β-glycerophosphate (10 mM) and cultured with three different concentrations of KB (5, 10, and 20 μM), and an ALP activity assay was done at 2, 3, 4, and 5 days of incubation. Control: KB non-treated cells. *: p < 0.05 vs. control. Figure S5 . Effects of kukoamine B (KB) on cell viability of primary-cultured monocytes. After induction of osteoclast differentiation by treatment of 30 ng/ml of M-CSF and 50 ng/ml of RANKL (Induction), cells were co-treated with three different concentrations of KB (5, 10, and 20 μM) for 6 days, and then cell viability was assessed. Figure S6 . Effects of kukoamine B (KB) on osteoclast differentiation of primary-cultured monocytes. After induction of osteoclast differentiation by treatment of 30 ng/ml of M-CSF and 50 ng/ml of RANKL (Induction), cells were co-treated with three different concentrations of KB (5, 10, and 20 μM) for 3 and 6 days, and tartrate-resistant acid phosphatase (TRAP) activity was assessed. *: p < 0.05 vs. Induction. Figure S7 . Effects of kukoamine B (KB) on osteoblast and osteoclast differentiations in the coculture of pre-osteoblasts and primary monocytes. Co-cultured MC3T3-E1 and primary monocyte cells were treated with osteoblast differentiation reagents, 50 μg/mL of ascorbic acid, and 10 mM of β-glycerophosphate and then co-treated with three different concentrations of KB (5, 10, and 20 μM) for 3 and 6 days. Alkaline phosphatase (ALP) activity (A) and tartrate-resistant acid phosphatase (TRAP) activity (B) were assessed in the co-culture cells. Control: KB non-treated cells. *: p < 0.05 vs. Control.
